← The Wire
SEPNNasdaq
Septerna, Inc.
Pharmaceutical Preparations · DE · CIK 1984086
Septerna discovers oral small molecule drugs for endocrinology, immunology, inflammation, and metabolic diseases using its Native Complex Platform
$1.62B
Market cap
$34.75
Last close
-6.9%
1D
-0.3%
5D
1.4M
Volume
Price · last 39 sessions+40.0%
May 4L $23.57 · H $37.34Jun 29
41
Total filings
May 11, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 11, 20268-KResults of OperationsMay 11, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KReg FD DisclosureApr 13, 202610-K10-KMar 9, 20268-KResults of OperationsMar 9, 20268-KReg FD Disclosure · Company UpdateMar 2, 20268-KReg FD DisclosureJan 12, 20268-KReg FD DisclosureJan 8, 202610-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KExecutive Change · Reg FD DisclosureSep 29, 20258-KReg FD DisclosureSep 3, 20258-KReg FD DisclosureAug 21, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KExecutive ChangeAug 4, 20258-KCompany UpdateJul 2, 20258-KShareholder VoteJun 18, 202510-Q10-QMay 15, 20258-KResults of OperationsMay 15, 20258-KMaterial Agreement · Reg FD DisclosureMay 14, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KReg FD DisclosureMar 3, 20258-KReg FD DisclosureFeb 18, 20258-KReg FD DisclosureJan 13, 20258-KExecutive Change · Reg FD DisclosureJan 6, 202510-Q10-QNov 20, 20248-KResults of OperationsNov 20, 2024SC 13DSC 13DNov 4, 2024SC 13GSC 13GNov 4, 2024SC 13GSCHEDULE 13GNov 1, 20248-KBylaw AmendmentOct 28, 2024424B4424B4Oct 25, 2024S-1/AS-1/AOct 24, 2024S-1/AS-1/AOct 21, 2024S-1S-1Oct 2, 2024
Insider Activity
In the 90 days to Mar 2, 2026: 2 sold $2.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Sell | 66,363 | $28.14 | $1.9M |
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Sell | 4,090 | $27.51 | $113K |
| Feb 18, 2026 | Bhatt ElizabethPresident and COO | Sell | 2,200 | $28.46 | $63K |
| Feb 18, 2026 | Bhatt ElizabethPresident and COO | Sell | 1,800 | $29.58 | $53K |
| Nov 10, 2025 | Long Daniel D.SVP, Drug Discovery | Sell | 3,501 | $18.06 | $63K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance